Who owns COLLPLANT BIOTECHNOLOGIES LT?
- Ticker: CLGN
- CUSIP Number: m2r51x116
Tip: Access positions for across all investors
Analyze quarterly positions in Collplant Biotechnologies Lt with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Collplant Biotechnologies Lt stock
Who bought or sold COLLPLANT BIOTECHNOLOGIES LT this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Gail Mannix | 531k | $2.8M | 13% | Mar 2024 |
|
St. Denis J. Villere & Co | 367k | $2.0M | 2% | Mar 2024 |
|
Brown Advisory Holdings Incorporated | 120k | $640k | 60% | Mar 2024 |
|
Benjamin F. Edwards & Company | 50k | $320k | 11% | Dec 2023 |
|
Citadel Advisors | 10k | $65k | 100% | Dec 2023 |
|
Bank of America Corporation | 7.3k | $47k | 0% | Dec 2023 |
|
Pnc Financial Services | 3.6k | $23k | 0% | Dec 2023 |
|
FNY Investment Advisers | 1.5k | $9.0k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 371.00 | $2.4k | 100% | Dec 2023 |
|
National Bank Of Canada /fi/ | 250.00 | $1.5k | 0% | Dec 2023 |
|
Focused Wealth Management | 242.00 | $1.5k | 0% | Dec 2023 |
|
Who sold out of Collplant Biotechnologies Lt?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Zurcher Kantonalbank | Dec 2023 | 23k | $148k |
UBS Group | Sep 2023 | 5.7k | $32k |
Geneos Wealth Management | Sep 2023 | 750.00 | $4.2k |